MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III studyQing Yuan Zhang, Xi Hu, Tao Sun et al.|Therapeutic Advances in Medical Oncology|2020Cited by 110
GLI1-Rearranged Enteric TumorJosé Jessurun, Juan Miguel Mosquera, Hussein Alnajar et al.|The American Journal of Surgical Pathology|2022Cited by 32